Xu, Feng
Novozymes Biotech, Inc.,
United States
2025 Rank: 55121
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Biotechnology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 154 out of 66225 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 55121 | 64334 |
| Total Cites | 7944 | 8324 |
| H-index | 34 | 34 |
| Hm-index | 13 | 13 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 1145 | 1171 |
| Number of Single+First Authored Papers | 26 | 26 |
| Total Cites to Single+First Authored Papers | 2827 | 2938 |
| Number of Single+First+Last Authored Papers | 42 | 42 |
| Total Cites to Single+First+Last Authored Papers | 3926 | 4068 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5235 | 5356 |
| Ratio of Total Citations to Distinct Citing Papers | 1.52 | 1.55 |
| Self-Citation Percentage |
4.57%
|
|
Xu, Feng
Ministry of Education of the People's Republic of China,
China
2024 Rank: 10385
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Biomedical Engineering
SubField 2:
Nanoscience & Nanotechnology
Rank in SubField 1: 37 out of 66541 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 10385 | 10303 |
| Total Cites | 28198 | 31688 |
| H-index | 82 | 88 |
| Hm-index | 32 | 34 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 410 | 430 |
| Number of Single+First Authored Papers | 82 | 82 |
| Total Cites to Single+First Authored Papers | 3154 | 3627 |
| Number of Single+First+Last Authored Papers | 350 | 350 |
| Total Cites to Single+First+Last Authored Papers | 13779 | 15373 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 24210 | 25670 |
| Ratio of Total Citations to Distinct Citing Papers | 1.16 | 1.23 |
| Self-Citation Percentage |
11.01%
|
|
Xu, Feng
Novozymes Biotech, Inc.,
United States
2023 Rank: 52033
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Biotechnology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 142 out of 59267 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 52033 | 59847 |
| Total Cites | 7127 | 7490 |
| H-index | 33 | 34 |
| Hm-index | 12 | 12 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 1059 | 1085 |
| Number of Single+First Authored Papers | 26 | 26 |
| Total Cites to Single+First Authored Papers | 2645 | 2759 |
| Number of Single+First+Last Authored Papers | 40 | 40 |
| Total Cites to Single+First+Last Authored Papers | 3470 | 3612 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4648 | 4767 |
| Ratio of Total Citations to Distinct Citing Papers | 1.53 | 1.57 |
| Self-Citation Percentage |
4.85%
|
|
Xu, Feng
Xi'an Jiaotong University,
China
2022 Rank: 79621
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Immunology
Rank in SubField 1: 3383 out of 201173 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 79621 | 81416 |
| Total Cites | 5413 | 6289 |
| H-index | 35 | 39 |
| Hm-index | 14 | 14 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 307 | 329 |
| Number of Single+First Authored Papers | 31 | 31 |
| Total Cites to Single+First Authored Papers | 1292 | 1420 |
| Number of Single+First+Last Authored Papers | 87 | 87 |
| Total Cites to Single+First+Last Authored Papers | 1985 | 2243 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4958 | 5559 |
| Ratio of Total Citations to Distinct Citing Papers | 1.09 | 1.13 |
| Self-Citation Percentage |
13.93%
|
|
Xu, Feng
Novozymes Biotech, Inc.,
United States
2021 Rank: 45228
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Biotechnology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 114 out of 52513 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 45228 | 53080 |
| Total Cites | 6591 | 6929 |
| H-index | 33 | 33 |
| Hm-index | 12 | 12 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 984 | 1010 |
| Number of Single+First Authored Papers | 26 | 26 |
| Total Cites to Single+First Authored Papers | 2464 | 2579 |
| Number of Single+First+Last Authored Papers | 41 | 41 |
| Total Cites to Single+First+Last Authored Papers | 3329 | 3475 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4262 | 4364 |
| Ratio of Total Citations to Distinct Citing Papers | 1.55 | 1.59 |
| Self-Citation Percentage |
4.88%
|
|
Xu, Feng
Novozymes Biotech, Inc.,
United States
2020 Rank: 41897
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Biotechnology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 117 out of 50343 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 41897 | 49325 |
| Total Cites | 6079 | 6394 |
| H-index | 33 | 33 |
| Hm-index | 12 | 12 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 934 | 958 |
| Number of Single+First Authored Papers | 25 | 25 |
| Total Cites to Single+First Authored Papers | 2345 | 2456 |
| Number of Single+First+Last Authored Papers | 40 | 40 |
| Total Cites to Single+First+Last Authored Papers | 3123 | 3265 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 3891 | 3988 |
| Ratio of Total Citations to Distinct Citing Papers | 1.56 | 1.60 |
| Self-Citation Percentage |
4.93%
|
|